Loading...
Back to narrative

Update shared on 31 Oct 2025

Fair value Decreased 4.39%
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
-41.3%
7D
-17.4%

Analysts have revised their fair value estimate for Utz Brands downward from $17.10 to $16.35 per share, citing a challenging outlook for U.S. consumer staples. This comes despite some improvement in profit margin and growth expectations.

Analyst Commentary

Bullish Takeaways

  • Bullish analysts note that Utz Brands continues to demonstrate resilience in profit margins, providing some support for the revised valuation.
  • There is optimism regarding the company’s ability to adapt its product mix, which could help drive volume growth despite current market pressures.
  • Analysts point out improvements in operational efficiency, suggesting potential for stronger execution in future quarters.

Bearish Takeaways

  • Bearish analysts caution that the overall outlook for the U.S. consumer staples sector remains challenging, and this weighs on growth projections for Utz Brands.
  • The lowering of price targets reflects concern over muted revenue growth and heightened competition in key segments.
  • Persistent uncertainty in consumer demand is seen as a risk to both execution and future earnings consistency.
  • Bearish analysts highlight that, despite recent margin improvements, visibility into sustainable long-term growth remains limited.

What's in the News

  • Utz Brands revised its 2025 fiscal year earnings guidance, now expecting approximately 3% Organic Net Sales growth, led by branded salty snacks. The company reaffirmed the rest of its outlook (Key Developments).
  • The company announced a multi-phase project to upgrade facilities across the Hanover, Pennsylvania campus. Plans include transforming headquarters into a modern Employee Hub, updating offices and workspaces, and planning for a future Community Center (Key Developments).
  • QuadMed, LLC partnered with Utz Brands to manage the Utz Health & Wellness Center. This collaboration aims to provide integrated health care for over 4,300 employees and their families, with expanded access to virtual and on-site services (Key Developments).

Valuation Changes

  • Fair Value Estimate has decreased from $17.10 to $16.35 per share, reflecting a modest reduction in analysts’ intrinsic valuation for Utz Brands.
  • Discount Rate remains unchanged at 6.78 percent. This indicates no shift in analysts’ risk assessment or required return assumptions.
  • Revenue Growth projection has risen slightly, moving from 2.69 percent to 2.84 percent based on updated forecasts.
  • Net Profit Margin expectation has increased from 7.75 percent to 8.15 percent. This signals improved profitability estimates.
  • Future P/E has fallen significantly from 28.0x to 16.2x, suggesting a lower valuation multiple is being applied to anticipated earnings.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.